Vivid Dx Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$15M
- Investors
-
7
Vivid Dx General Information
Description
Developer of a precision diagnostic platform designed for rapid sepsis and antimicrobial resistance (AMR) detection. The company's diagnostic system combines single-cell Raman spectroscopy, a scalable Raman spectra database, and AI-driven analysis, enabling hospitals, clinical laboratories, and healthcare providers to conduct rapid pathogen identification and antibiotic susceptibility testing, while making life-saving treatment decisions without blood culture delays.
Contact Information
Website
www.vivid-dx.comCorporate Office
- Floor 5 Sherrington Building Magdalen Centre
- Robert Robinson Avenue, Littlemore
- Oxford OX4 4GA
- England, United Kingdom
Corporate Office
- Floor 5 Sherrington Building Magdalen Centre
- Robert Robinson Avenue, Littlemore
- Oxford OX4 4GA
- England, United Kingdom
Vivid Dx Timeline
Vivid Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 08-Jun-2026 | $15M | Completed | Generating Revenue | ||
| 4. Grant | 01-May-2025 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Apr-2024 | Completed | Generating Revenue | |||
| 2. Grant | 05-Jul-2023 | $63.3K | Completed | Generating Revenue | ||
| 1. University Spin-Out | 01-Jan-2022 | Completed | Generating Revenue |
Vivid Dx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred Shares | ||||||||
| Preferred Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Vivid Dx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vivid Dx Patents
Vivid Dx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026099770-A1 | Systems and methods of raman bandpass microbial detection | Pending | 07-Nov-2024 |
Vivid Dx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vivid Dx Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cedars-Sinai | Corporation | Minority | ||
| Jameel Investment Management Company | Corporate Venture Capital | Minority | ||
| UK Research and Innovation | Government | |||
| Oxford Science Enterprises | Venture Capital | Minority | ||
| Innovate UK | Government |
Vivid Dx FAQs
-
When was Vivid Dx founded?
Vivid Dx was founded in 2022.
-
Where is Vivid Dx headquartered?
Vivid Dx is headquartered in Oxford, United Kingdom.
-
What is the size of Vivid Dx?
Vivid Dx has 15 total employees.
-
What industry is Vivid Dx in?
Vivid Dx’s primary industry is Diagnostic Equipment.
-
Is Vivid Dx a private or public company?
Vivid Dx is a Private company.
-
What is Vivid Dx’s current revenue?
The current revenue for Vivid Dx is .
-
How much funding has Vivid Dx raised over time?
Vivid Dx has raised $19.3M.
-
Who are Vivid Dx’s investors?
Cedars-Sinai, Jameel Investment Management Company, UK Research and Innovation, Oxford Science Enterprises, and Innovate UK are 5 of 7 investors who have invested in Vivid Dx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
